Emanuela Arena

Via S. Sofia 64
Catania, 95100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Corrigendum to "(+)-Pentazocine reduces oxidative stress and apoptosis in microglia following hypoxia/reoxygenation injury" [Neurosci. Lett. 626 (2016) 142-148].

Corrigendum to "(+)-Pentazocine reduces oxidative stress and apoptosis in microglia following hypoxia/reoxygenation injury" [Neurosci. Lett. 626 (2016) 142-148].

Journal: Neuroscience letters

Published: April 29, 2023

Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects.

Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects.

Journal: ACS chemical neuroscience

Published: May 21, 2021

Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation.

Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation.

Journal: ACS medicinal chemistry letters

Published: December 29, 2019

Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists.

Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists.

Journal: ACS medicinal chemistry letters

Published: November 26, 2019

Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.

Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.

Journal: European journal of medicinal chemistry

Published: March 13, 2019

(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist.

(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist.

Journal: European journal of medicinal chemistry

Published: November 23, 2018

Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives.

Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 16, 2018

(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties.

(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties.

Journal: Journal of medicinal chemistry

Published: December 09, 2017

Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?

Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?

Journal: Future medicinal chemistry

Published: November 30, 2017

Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect.

Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect.

Journal: Journal of medicinal chemistry

Published: November 28, 2017

Development of novel LP1-based analogues with enhanced delta opioid receptor profile.

Development of novel LP1-based analogues with enhanced delta opioid receptor profile.

Journal: Bioorganic & medicinal chemistry

Published: May 25, 2017

Role of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries.

Role of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries.

Journal: Clinical science (London, England : 1979)

Published: February 16, 2017

Showing 1-12 of 22

Last Updated: 09/26/2026